Research Journal of Pharmacy and Technology
SCOPUS
  • Year: 2019
  • Volume: 12
  • Issue: 2

Stability indicating HPLC-DAD method for the determination of Oxcarbazepine-An Anticonvulsant

Department of Pharmaceutical Analysis & Quality Assurance, GITAM Institute of Pharmacy, GITAM (Deemed to be University), Visakhapatnam, Andhra pradesh-530045, India

*Corresponding Author E-mail: debi.rips@gmail.com

Online published on 18 April, 2019.

Abstract

Oxcarbazepine is an anticonvulsant drug used for the treatment of epilepsy. It acts by decreasing the abnormal electrical activity in the brain. A new stability indicating HPLC method was developed for the quantification of Oxcarbazepine in tablets. Waters e2695 Separations module with Waters 2489 UV detector with Hypersil BDS C18 column (250 mm x 4.6 mm, 5μ) was operated with column temperature 50°C. The detector was monitored at 215 nm and the chromatographic study was run for 20 min. Linearity was observed over 5.0–150 μg/mL with linear regression equation y = 47, 910x + 6493.8 with correlation coefficient R² = 0.9999. The LOQ and LOD were found to be 4.5129 μg/mL and 1.4898 μg/mL respectively. Forced degradation studies were performed for Oxcarbazepine capsules and the method was validated as per ICH guidelines.

Keywords

Oxcarbazepine, RP-HPLC, stability indicating, validation, ICH guidelines